Article Text

PO-0815 Moyamoya In Paediatric Patients
  1. J Cotrim1,
  2. V Rocha2,
  3. A Leite3,
  4. M Vila Real3,
  5. F Santos3
  1. 1Pediatrics Department, Centro Hospitalar de Trás-Os-Montes E Alto Douro, Vila Real, Portugal
  2. 2Pediatrics Department, Centro Hospitalar de Tâmega E Sousa, Penafiel, Portugal
  3. 3Pediatrics Department, Centro Hospitalar de Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal

Abstract

Background and aims Moyamoya disease (MMD) is an uncommon chronic progressive cerebrovascular occlusive disease of the bilateral internal carotid arteries that leads to a compensatory abnormal vascular network at the base of the brain. Reported incidence in the USA is approximately 0,086 per 100,000 patients. It can be primary or associated with other conditions.

Methods Retrospective analysis of clinical files of patients diagnosed with MMD currently followed in the Paediatric Neurology ambulatory unit of Vila Nova de Gaia Hospital, Portugal.

Results There are three cases of MMD, all male, two associated with neurofibromatosis type 1 (NF-1) and one case of primary MMD. All diagnosis were based on brain magnetic resonance angiography (MRA) findings: stenotic lesions in the distal carotid arteries, increased signal in the leptomeninges and perivascular spaces. Idiopathic MMD presented in an 11 year old with acute hemiparesis and disartria. Brain CT revealed an ischaemic stroke and MRA was consistent with MMD. In both cases of NF-1, MMD was diagnosed during follow up of the disease. Patients were 1 and 4 years old and were assymptomatic at time of diagnosis. In one case, neurologic symptoms developed during follow-up and revascularisation surgery was necessary.

Conclusions The natural history of MMD tends to be progressive. Association between MMD and NF-1 is rare, but poses a potencial risk. In previously healthy patients who present with acute neurologic symptoms, a high index of suspicion is necessary. In both cases, prompt diagnosis and appropriate management are crucial to improve long-term prognosis.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.